nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentazocine—Lightheadedness—Ramipril—type 1 diabetes mellitus	0.0245	0.0528	CcSEcCtD
Pentazocine—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.0179	0.0386	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.0179	0.0386	CcSEcCtD
Pentazocine—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.017	0.0367	CcSEcCtD
Pentazocine—Sweating increased—Ramipril—type 1 diabetes mellitus	0.0167	0.0361	CcSEcCtD
Pentazocine—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.0165	0.0355	CcSEcCtD
Pentazocine—Sweating—Ramipril—type 1 diabetes mellitus	0.0147	0.0317	CcSEcCtD
Pentazocine—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.0143	0.0308	CcSEcCtD
Pentazocine—Visual impairment—Ramipril—type 1 diabetes mellitus	0.0133	0.0286	CcSEcCtD
Pentazocine—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.013	0.028	CcSEcCtD
Pentazocine—Tinnitus—Ramipril—type 1 diabetes mellitus	0.0128	0.0276	CcSEcCtD
Pentazocine—Flushing—Ramipril—type 1 diabetes mellitus	0.0128	0.0275	CcSEcCtD
Pentazocine—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.0117	0.0253	CcSEcCtD
Pentazocine—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.0115	0.0248	CcSEcCtD
Pentazocine—Tremor—Ramipril—type 1 diabetes mellitus	0.0112	0.0242	CcSEcCtD
Pentazocine—Agitation—Ramipril—type 1 diabetes mellitus	0.011	0.0237	CcSEcCtD
Pentazocine—Vertigo—Ramipril—type 1 diabetes mellitus	0.0108	0.0232	CcSEcCtD
Pentazocine—Syncope—Ramipril—type 1 diabetes mellitus	0.0107	0.0231	CcSEcCtD
Pentazocine—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.0105	0.0227	CcSEcCtD
Pentazocine—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00998	0.0215	CcSEcCtD
Pentazocine—Confusional state—Ramipril—type 1 diabetes mellitus	0.00986	0.0212	CcSEcCtD
Pentazocine—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00978	0.0211	CcSEcCtD
Pentazocine—Shock—Ramipril—type 1 diabetes mellitus	0.00962	0.0207	CcSEcCtD
Pentazocine—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00954	0.0206	CcSEcCtD
Pentazocine—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00945	0.0204	CcSEcCtD
Pentazocine—Anorexia—Ramipril—type 1 diabetes mellitus	0.00932	0.0201	CcSEcCtD
Pentazocine—Hypotension—Ramipril—type 1 diabetes mellitus	0.00914	0.0197	CcSEcCtD
Pentazocine—Insomnia—Ramipril—type 1 diabetes mellitus	0.00884	0.019	CcSEcCtD
Pentazocine—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00878	0.0189	CcSEcCtD
Pentazocine—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00872	0.0188	CcSEcCtD
Pentazocine—Somnolence—Ramipril—type 1 diabetes mellitus	0.00869	0.0187	CcSEcCtD
Pentazocine—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.0085	0.0183	CcSEcCtD
Pentazocine—Constipation—Ramipril—type 1 diabetes mellitus	0.00836	0.018	CcSEcCtD
Pentazocine—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00806	0.0174	CcSEcCtD
Pentazocine—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.0072	0.0155	CcSEcCtD
Pentazocine—Asthenia—Ramipril—type 1 diabetes mellitus	0.00702	0.0151	CcSEcCtD
Pentazocine—Pruritus—Ramipril—type 1 diabetes mellitus	0.00692	0.0149	CcSEcCtD
Pentazocine—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00669	0.0144	CcSEcCtD
Pentazocine—Dizziness—Ramipril—type 1 diabetes mellitus	0.00647	0.0139	CcSEcCtD
Pentazocine—Vomiting—Ramipril—type 1 diabetes mellitus	0.00622	0.0134	CcSEcCtD
Pentazocine—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00616	0.0133	CcSEcCtD
Pentazocine—Headache—Ramipril—type 1 diabetes mellitus	0.00613	0.0132	CcSEcCtD
Pentazocine—Nausea—Ramipril—type 1 diabetes mellitus	0.00581	0.0125	CcSEcCtD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.00257	0.0048	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—GAL—type 1 diabetes mellitus	0.00252	0.0047	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.00249	0.00465	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.00249	0.00465	CbGpPWpGaD
Pentazocine—OPRD1—Peptide ligand-binding receptors—CCR5—type 1 diabetes mellitus	0.00248	0.00463	CbGpPWpGaD
Pentazocine—OPRM1—G alpha (i) signalling events—SST—type 1 diabetes mellitus	0.00241	0.0045	CbGpPWpGaD
Pentazocine—OPRM1—Peptide ligand-binding receptors—CXCL10—type 1 diabetes mellitus	0.00237	0.00443	CbGpPWpGaD
Pentazocine—OPRK1—G alpha (i) signalling events—CXCL10—type 1 diabetes mellitus	0.00237	0.00442	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.00234	0.00437	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.00227	0.00423	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.00226	0.00421	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.00224	0.00418	CbGpPWpGaD
Pentazocine—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	0.00222	0.00415	CbGpPWpGaD
Pentazocine—EBP—Metabolism—ITPR3—type 1 diabetes mellitus	0.00222	0.00415	CbGpPWpGaD
Pentazocine—OPRK1—Peptide ligand-binding receptors—CCR5—type 1 diabetes mellitus	0.00218	0.00406	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.00215	0.00401	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—GAL—type 1 diabetes mellitus	0.00213	0.00397	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.0021	0.00393	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.0021	0.00393	CbGpPWpGaD
Pentazocine—OPRM1—TCR Signaling Pathway—CD4—type 1 diabetes mellitus	0.0021	0.00392	CbGpPWpGaD
Pentazocine—EBP—Metabolism—HBA1—type 1 diabetes mellitus	0.00209	0.00391	CbGpPWpGaD
Pentazocine—OPRD1—G alpha (i) signalling events—CCR5—type 1 diabetes mellitus	0.00209	0.00391	CbGpPWpGaD
Pentazocine—EBP—Metabolism—APOC3—type 1 diabetes mellitus	0.00208	0.00388	CbGpPWpGaD
Pentazocine—EBP—Metabolism—GSTT1—type 1 diabetes mellitus	0.00204	0.00382	CbGpPWpGaD
Pentazocine—OPRM1—G alpha (i) signalling events—CXCL10—type 1 diabetes mellitus	0.002	0.00374	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.00198	0.00369	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—SST—type 1 diabetes mellitus	0.00197	0.00367	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.00197	0.00367	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.00196	0.00366	CbGpPWpGaD
Pentazocine—OPRD1—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.00194	0.00363	CbGpPWpGaD
Pentazocine—OPRM1—TCR Signaling Pathway—IL1B—type 1 diabetes mellitus	0.00194	0.00362	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.00191	0.00357	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.00191	0.00356	CbGpPWpGaD
Pentazocine—EBP—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.00188	0.00352	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.00188	0.00351	CbGpPWpGaD
Pentazocine—OPRM1—Peptide ligand-binding receptors—CCR5—type 1 diabetes mellitus	0.00184	0.00343	CbGpPWpGaD
Pentazocine—OPRK1—G alpha (i) signalling events—CCR5—type 1 diabetes mellitus	0.00184	0.00343	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.00175	0.00327	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—SST—type 1 diabetes mellitus	0.00173	0.00322	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.00172	0.00321	CbGpPWpGaD
Pentazocine—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.0017	0.00318	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.00166	0.00311	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.00166	0.0031	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.00163	0.00305	CbGpPWpGaD
Pentazocine—EBP—Metabolism—GCG—type 1 diabetes mellitus	0.00163	0.00304	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.00162	0.00303	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.0016	0.00299	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.00159	0.00297	CbGpPWpGaD
Pentazocine—OPRM1—G alpha (i) signalling events—CCR5—type 1 diabetes mellitus	0.00155	0.0029	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.00154	0.00287	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.00151	0.00282	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.00147	0.00275	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.00146	0.00273	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—SST—type 1 diabetes mellitus	0.00146	0.00272	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.00146	0.00272	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.00146	0.00272	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.00145	0.00271	CbGpPWpGaD
Pentazocine—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.00144	0.00269	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.00143	0.00268	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.00142	0.00266	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.00141	0.00263	CbGpPWpGaD
Pentazocine—EBP—Metabolism—CAT—type 1 diabetes mellitus	0.00138	0.00257	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.00137	0.00256	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.00135	0.00253	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.00132	0.00247	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.0013	0.00243	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.00129	0.00241	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.00128	0.00238	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.00128	0.00238	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.00127	0.00237	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.00127	0.00236	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.00123	0.0023	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.00123	0.0023	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.00121	0.00226	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.0012	0.00224	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.0012	0.00224	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.00119	0.00222	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.00119	0.00222	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.00115	0.00215	CbGpPWpGaD
Pentazocine—OPRM1—TCR Signaling Pathway—IL6—type 1 diabetes mellitus	0.00114	0.00212	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.00112	0.00209	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.00111	0.00208	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.00111	0.00208	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.00111	0.00207	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.00111	0.00207	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.00109	0.00204	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.00108	0.00202	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.00108	0.00202	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.00108	0.00201	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.00101	0.00189	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—SST—type 1 diabetes mellitus	0.00101	0.00188	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.00101	0.00188	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.00101	0.00188	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.001	0.00187	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000991	0.00185	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000975	0.00182	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000971	0.00181	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000954	0.00178	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.00094	0.00175	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.000939	0.00175	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000926	0.00173	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000924	0.00172	CbGpPWpGaD
Pentazocine—EBP—Metabolism—INS—type 1 diabetes mellitus	0.000915	0.00171	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.000911	0.0017	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.0009	0.00168	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000885	0.00165	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000881	0.00165	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—GAL—type 1 diabetes mellitus	0.00087	0.00162	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000869	0.00162	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000866	0.00162	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000861	0.00161	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000861	0.00161	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000852	0.00159	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000841	0.00157	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000839	0.00157	CbGpPWpGaD
Pentazocine—EBP—Metabolism—ALB—type 1 diabetes mellitus	0.000839	0.00157	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000836	0.00156	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000824	0.00154	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.00082	0.00153	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000812	0.00152	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.00081	0.00151	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000809	0.00151	CbGpPWpGaD
Pentazocine—EBP—Metabolism—NOS3—type 1 diabetes mellitus	0.000802	0.0015	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000789	0.00147	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000763	0.00142	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.00076	0.00142	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000755	0.00141	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000755	0.00141	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000748	0.0014	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000745	0.00139	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000738	0.00138	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000736	0.00137	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000734	0.00137	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000726	0.00136	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000716	0.00134	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000709	0.00132	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000707	0.00132	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000706	0.00132	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000687	0.00128	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000685	0.00128	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000684	0.00128	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000679	0.00127	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000679	0.00127	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000667	0.00125	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000651	0.00121	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000645	0.0012	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000642	0.0012	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000641	0.0012	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000638	0.00119	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000638	0.00119	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000637	0.00119	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000628	0.00117	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000623	0.00116	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000622	0.00116	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000619	0.00116	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.0006	0.00112	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000599	0.00112	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SST—type 1 diabetes mellitus	0.000596	0.00111	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000596	0.00111	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000596	0.00111	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000594	0.00111	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000571	0.00107	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000562	0.00105	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000538	0.001	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000532	0.000992	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000531	0.000991	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000523	0.000977	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SST—type 1 diabetes mellitus	0.000523	0.000976	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000521	0.000972	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000512	0.000955	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000507	0.000946	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000503	0.00094	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000503	0.00094	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000497	0.000928	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000496	0.000925	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000482	0.0009	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000475	0.000887	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000466	0.00087	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000452	0.000843	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.00045	0.00084	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000449	0.000838	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SST—type 1 diabetes mellitus	0.000442	0.000825	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.00044	0.000822	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000436	0.000814	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000435	0.000811	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000433	0.000809	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000414	0.000773	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000411	0.000768	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000396	0.00074	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000395	0.000737	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000394	0.000735	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000391	0.00073	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000384	0.000718	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CD86—type 1 diabetes mellitus	0.00038	0.000709	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000379	0.000708	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000379	0.000707	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000376	0.000702	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000368	0.000688	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000367	0.000686	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000363	0.000678	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000361	0.000673	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000343	0.00064	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000337	0.000629	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000335	0.000625	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000334	0.000623	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000332	0.00062	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.00033	0.000615	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000321	0.0006	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000316	0.00059	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000307	0.000573	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000305	0.000569	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—INS—type 1 diabetes mellitus	0.000299	0.000558	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.00029	0.000541	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000289	0.000539	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000288	0.000537	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000285	0.000532	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000281	0.000524	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000279	0.00052	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000277	0.000518	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000267	0.000498	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000262	0.000489	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—INS—type 1 diabetes mellitus	0.000262	0.000489	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000253	0.000473	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000252	0.000471	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000234	0.000437	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000234	0.000437	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.00023	0.000429	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000222	0.000415	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000222	0.000415	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—INS—type 1 diabetes mellitus	0.000221	0.000413	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000221	0.000412	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000214	0.0004	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000213	0.000398	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000198	0.000369	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000195	0.000364	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000195	0.000364	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000194	0.000362	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000194	0.000362	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000187	0.000349	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.00017	0.000317	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000165	0.000308	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000165	0.000307	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000164	0.000306	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000164	0.000306	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000149	0.000278	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000138	0.000259	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL6—type 1 diabetes mellitus	0.000131	0.000244	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000126	0.000235	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL6—type 1 diabetes mellitus	0.000114	0.000214	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL6—type 1 diabetes mellitus	9.67e-05	0.000181	CbGpPWpGaD
